These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 10846517)
1. Menopausal hormones and breast cancer in a biracial population. Moorman PG; Kuwabara H; Millikan RC; Newman B Am J Public Health; 2000 Jun; 90(6):966-71. PubMed ID: 10846517 [TBL] [Abstract][Full Text] [Related]
2. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study. DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827 [TBL] [Abstract][Full Text] [Related]
3. Associations of Premenopausal Hysterectomy and Oophorectomy With Breast Cancer Among Black and White Women: The Carolina Breast Cancer Study, 1993-2001. Robinson WR; Nichols HB; Tse CK; Olshan AF; Troester MA Am J Epidemiol; 2016 Sep; 184(5):388-99. PubMed ID: 27555487 [TBL] [Abstract][Full Text] [Related]
4. Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women. Chlebowski RT; Aragaki AK; Anderson GL; Prentice RL Cancer; 2020 Jul; 126(13):2956-2964. PubMed ID: 32212335 [TBL] [Abstract][Full Text] [Related]
5. Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Hall IJ; Newman B; Millikan RC; Moorman PG Am J Epidemiol; 2000 Apr; 151(8):754-64. PubMed ID: 10965972 [TBL] [Abstract][Full Text] [Related]
6. Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. Mayberry RM Ann Epidemiol; 1994 May; 4(3):205-13. PubMed ID: 8055121 [TBL] [Abstract][Full Text] [Related]
7. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Troisi RJ; Speizer FE; Willett WC; Trichopoulos D; Rosner B Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1183-8. PubMed ID: 7551368 [TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study. Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700 [TBL] [Abstract][Full Text] [Related]
9. Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women. Brinton LA; Gammon MD; Malone KE; Schoenberg JB; Daling JR; Coates RJ Contraception; 1997 Apr; 55(4):197-203. PubMed ID: 9179450 [TBL] [Abstract][Full Text] [Related]
10. Menopausal hormones and risk of ovarian cancer. Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062 [TBL] [Abstract][Full Text] [Related]
11. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study. Williams LA; Olshan AF; Tse CK; Bell ME; Troester MA Cancer Causes Control; 2016 Feb; 27(2):259-69. PubMed ID: 26705260 [TBL] [Abstract][Full Text] [Related]
12. Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Millikan R; DeVoto E; Duell EJ; Tse CK; Savitz DA; Beach J; Edmiston S; Jackson S; Newman B Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1233-40. PubMed ID: 11097232 [TBL] [Abstract][Full Text] [Related]
13. Alcohol consumption and breast cancer among black and white women in North Carolina (United States). Kinney AY; Millikan RC; Lin YH; Moorman PG; Newman B Cancer Causes Control; 2000 Apr; 11(4):345-57. PubMed ID: 10843445 [TBL] [Abstract][Full Text] [Related]
14. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age. Li CI; Daling JR; Haugen KL; Tang MT; Porter PL; Malone KE Breast Cancer Res Treat; 2014 Jun; 145(2):481-9. PubMed ID: 24748570 [TBL] [Abstract][Full Text] [Related]
15. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. La Vecchia C; Ron E; Franceschi S; Dal Maso L; Mark SD; Chatenoud L; Braga C; Preston-Martin S; McTiernan A; Kolonel L; Mabuchi K; Jin F; Wingren G; Galanti MR; Hallquist A; Lund E; Levi F; Linos D; Negri E Cancer Causes Control; 1999 Apr; 10(2):157-66. PubMed ID: 10231164 [TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives, menopausal estrogens, and the risk of breast cancer: a case-control study in Greece. Lipworth L; Katsouyanni K; Stuver S; Samoli E; Hankinson SE; Trichopoulos D Int J Cancer; 1995 Sep; 62(5):548-51. PubMed ID: 7665225 [TBL] [Abstract][Full Text] [Related]
17. Radial bone density and breast cancer risk in white and African-American women. Nelson DA; Darga LL; Simon MS; Severson RK Osteoporos Int; 2004 Jul; 15(7):535-40. PubMed ID: 14760517 [TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy. Brinton LA; Brogan DR; Coates RJ; Swanson CA; Potischman N; Stanford JL Menopause; 2018 Nov; 25(11):1195-1200. PubMed ID: 30358713 [TBL] [Abstract][Full Text] [Related]
20. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]